C
C the Signs
Using AI to help healthcare professionals detect cancer early and streamline referral pathways across health systems
About C the Signs
C the Signs is a healthtech company using artificial intelligence to help healthcare professionals detect cancer at the earliest possible stage, when treatment is most effective. The platform supports clinicians by analyzing patient symptoms, clinical data, and risk factors in real time to recommend appropriate diagnostic and referral pathways. Designed to integrate into primary care and wider health system workflows, C the Signs bridges the gap between complex cancer guidelines and practical clinical decision-making. The tool is particularly valuable in supporting earlier diagnosis across all cancer types, including rare and hard-to-detect cancers. It improves patient outcomes by enabling faster referrals, reducing diagnostic delays, and supporting more personalized care. With a strong focus on population health, the platform also helps healthcare systems identify disparities in care access, streamline operational efficiency, and align with national cancer targets. C the Signs is trusted by healthcare providers and systems in the UK and internationally, playing a crucial role in transforming how cancer is diagnosed and managed at scale.
Source: Dealroom company dataNews
Open roles
C the Signs in the London ecosystem
The C the Signs office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
SBRI Healthcare
Series A4 investors entered at this stage
MMC Ventures
Ataraxia VC
Acequia Capital
Khosla Ventures
Source: Dealroom Talent Intelligence.
See C the Signs on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


